Jump Financial’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-45,634
Closed -$561K – 2078
2023
Q3
$561K Buy
45,634
+6,824
+18% +$101K 0.02% 962
2023
Q2
$624K Buy
38,810
+23,443
+153% +$386K 0.02% 922
2023
Q1
$268K Sell
15,367
-78,129
-84% -$1.11M 0.01% 1166
2022
Q4
$864K Sell
93,496
-21,604
-19% -$201K 0.05% 544
2022
Q3
$991K Sell
115,100
-5,000
-4% -$49.7K 0.04% 624
2022
Q2
$979K Sell
120,100
-2,905
-2% -$27.7K 0.04% 585
2022
Q1
$1.49M Buy
123,005
+102,743
+507% +$2.16M 0.06% 368
2021
Q4
$692K Buy
+20,262
New +$794K 0.04% 515

Other funds holding NEO

Jump Financial's NEO Position: Q4 2023 in Review

Jump Financial sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 45,634 shares — an estimated $561K sold.

Jump Financial first reported a position in NEO in Q4 2021 and held it in 8 quarters. The position peaked at $1.49M in Q1 2022. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Jump Financial reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • Jump Financial sold 45,634 NeoGenomics shares in Q4 2023, an estimated $561K.
  • Jump Financial first reported a position in NeoGenomics in Q4 2021 and held it in 8 quarters.
  • Jump Financial's NeoGenomics position peaked at $1.49M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.